Effects of Genetic Variability on Rifampicin and Isoniazid Pharmacokinetics in South African Patients with Recurrent Tuberculosis

Abstract

Clinical relevance of the effects of genetic variation on isoniazid concentrations and low first-line tuberculosis drug exposures observed require further investigation.